{
    "nct_id": "NCT03441113",
    "official_title": "Extended Access of Momelotinib for Subjects With Primary Myelofibrosis (PMF) or Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)",
    "inclusion_criteria": "* Currently enrolled in Studies GS-US-352-0101, GS-US-352-1214, GS-US-352-1154, or SRA-MMB-301\n* Able to comprehend and willing to sign the informed consent form\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Known hypersensitivity to MMB, its metabolites, or formulation excipients\n\nNOTE: Other protocol defined Inclusion/ Exclusion criteria may apply.",
    "miscellaneous_criteria": "Key"
}